TOCQUEVILLE ASSET MANAGEMENT L.P. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$390,000
-37.5%
4,0000.0%0.01%
-46.2%
Q2 2020$624,000
+8.1%
4,0000.0%0.01%
-7.1%
Q1 2020$577,000
-29.5%
4,0000.0%0.01%
+16.7%
Q4 2019$818,000
+63.9%
4,000
-35.6%
0.01%
+71.4%
Q3 2019$499,000
-14.6%
6,215
+0.4%
0.01%
-12.5%
Q2 2019$584,0006,1900.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders